HIV1RNAQUANTITATIVE, REALTIMEPCRWITHCD3/ CD4(IMMUNE DEFICIENCY PANEL 4) MARKERS

SKU: KLOS322 Category:

Description

The test you mentioned combines two different types of assays:

  1. HIV-1 RNA Quantitative Real-Time PCR: This part of the test measures the amount of HIV-1 RNA, the genetic material of the human immunodeficiency virus (HIV), in the blood. It is a sensitive method for detecting and quantifying the viral load, which refers to the amount of HIV virus present in the bloodstream. Real-time PCR (polymerase chain reaction) is a highly accurate and efficient technique for detecting and measuring viral RNA. Monitoring the viral load is essential in managing HIV infection, as it helps assess disease progression, monitor response to antiretroviral therapy (ART), and guide treatment decisions.
  2. CD3/CD4 (Immune Deficiency Panel 4) Markers: This part of the test measures the levels of CD3 and CD4 lymphocytes in the blood. CD3 and CD4 are cell surface markers found on certain types of white blood cells, particularly T lymphocytes (T cells). CD4 T cells are a key component of the immune system and play a central role in coordinating the immune response to infections. HIV specifically targets and destroys CD4 T cells, leading to immune deficiency and increasing susceptibility to opportunistic infections. Monitoring CD4 T cell counts is important in assessing immune function and guiding the management of HIV infection. A decline in CD4 T cell count is associated with increased risk of opportunistic infections and progression to acquired immunodeficiency syndrome (AIDS).

The combination of HIV-1 RNA quantification and CD3/CD4 marker measurement in a single test panel provides comprehensive information about both the viral load and the immune status of the individual with HIV infection. This information is crucial for determining the stage of HIV infection, monitoring disease progression, evaluating response to antiretroviral therapy, and guiding clinical management decisions.

Overall, the test helps healthcare providers assess the effectiveness of treatment and determine when adjustments to therapy may be necessary to control HIV replication and preserve immune function. It plays a vital role in the ongoing management and care of individuals living with HIV/AIDS.

Reviews

There are no reviews yet.

Be the first to review “HIV1RNAQUANTITATIVE, REALTIMEPCRWITHCD3/ CD4(IMMUNE DEFICIENCY PANEL 4) MARKERS”

Your email address will not be published. Required fields are marked *